St. Rita’s Medical Center now offers non-surgical treatment for tricuspid regurgitation or leaky heart valve, a condition in ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

The overall evidence for the procedure is “insufficient” at present, but good enough to allow coverage, the agency says.

Background: Persistent significant tricuspid regurgitation (TR) after successful left-sided valve surgery is frequently reported. Objectives: To evaluate the incidence, risk factors and clinical ...

Looking for data on who's getting school vouchers or which cars are illegally driven? Loopholes need fixing first.

NY Valves 2025 Up Next Presentation NY Valves 2025 Transcatheter Edge-to-Edge Repair of the Systemic Atrioventricular Valve in a Patient With Congenitally Corrected Transposition of the Great Arteries ...

NEW YORK CITY -- Newer technology strengthened the case for single-shot transcatheter edge-to-edge repair (TEER) for concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR ...

The EVOQUE valve will be available in four sizes, all delivered through the same low-profile transfemoral 28F system. "Patients suffering from severe tricuspid regurgitation endure debilitating ...

MISSISSAUGA, ON, June 23, 2025 /CNW/ – Edwards Lifesciences Corporation today announced the company’s EVOQUE tricuspid valve replacement system has received… ...